BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33939629)

  • 1. Mapping Schistosoma haematobium for Novel Interventions against Female Genital Schistosomiasis and Associated HIV Risk in KwaZulu-Natal, South Africa.
    Livingston M; Pillay P; Zulu SG; Sandvik L; Kvalsvig JD; Gagai S; Galappaththi-Arachchige HN; Kleppa E; Ndhlovu P; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
    Am J Trop Med Hyg; 2021 May; 104(6):2055-2064. PubMed ID: 33939629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for participation in mass-treatment and female genital schistosomiasis re-investigation, and the effect of praziquantel treatment in South African adolescents.
    Nemungadi TG; Kleppa E; Galappaththi-Arachchige HN; Pillay P; Gundersen SG; Vennervald BJ; Ndhlovu PD; Taylor M; Naidoo S; Kjetland EF
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0011798. PubMed ID: 38536861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.
    Ndeffo Mbah ML; Gilbert JA; Galvani AP
    Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
    Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
    Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Female Genital Schistosomiasis and Other Infections of the Lower Genital Tract in Adolescent Girls and Young Women: A Cross-Sectional Study in South Africa.
    Shukla JD; Kleppa E; Holmen S; Ndhlovu PD; Mtshali A; Sebitloane M; Vennervald BJ; Gundersen SG; Taylor M; Kjetland EF
    J Low Genit Tract Dis; 2023 Jul; 27(3):291-296. PubMed ID: 37379442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
    Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
    BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
    Ndeffo Mbah ML; Poolman EM; Atkins KE; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
    PLoS Negl Trop Dis; 2013; 7(8):e2346. PubMed ID: 23936578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: Repeated cross-sectional studies.
    Trippler L; Ame SM; Hattendorf J; Juma S; Abubakar S; Ali SM; Kabole F; Rollinson D; Knopp S
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009127. PubMed ID: 33577601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa.
    Hegertun IE; Sulheim Gundersen KM; Kleppa E; Zulu SG; Gundersen SG; Taylor M; Kvalsvig JD; Kjetland EF
    PLoS Negl Trop Dis; 2013; 7(3):e2104. PubMed ID: 23556009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of Egg Excretion of
    Niaré DS; Doumtabe D; Ongoiba A; Sidibé K; Traoré A; Sangala J; Kayentao K; Tran TM; Crompton PD; Traoré B; Doumbo OK
    Bull Soc Pathol Exot; 2018; 111(2):114-120. PubMed ID: 30789237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis.
    Sturt AS; Webb EL; Patterson C; Phiri CR; Mweene T; Kjetland EF; Mudenda M; Mapani J; Mutengo MM; Chipeta J; van Dam GJ; Corstjens PLAM; Ayles H; Hayes RJ; Hansingo I; Cools P; van Lieshout L; Helmby H; McComsey GA; Francis SC; Bustinduy AL
    Front Immunol; 2021; 12():620657. PubMed ID: 33737927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.
    Downs JA; Kabangila R; Verweij JJ; Jaka H; Peck RN; Kalluvya SE; Changalucha JM; Johnson WD; van Lieshout L; Fitzgerald DW
    Trop Med Int Health; 2013 Sep; 18(9):1090-1096. PubMed ID: 23937701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women.
    Hotez PJ; Harrison W; Fenwick A; Bustinduy AL; Ducker C; Sabina Mbabazi P; Engels D; Floerecke Kjetland E
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007025. PubMed ID: 30946746
    [No Abstract]   [Full Text] [Related]  

  • 15. Break Out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era.
    Brindley PJ; Hotez PJ
    PLoS Negl Trop Dis; 2013; 7(3):e1961. PubMed ID: 23556007
    [No Abstract]   [Full Text] [Related]  

  • 16. Schistosoma haematobium infection and CD4+ T-cell levels: a cross-sectional study of young South African women.
    Kleppa E; Klinge KF; Galaphaththi-Arachchige HN; Holmen SD; Lillebø K; Onsrud M; Gundersen SG; Taylor M; Ndhlovu P; Kjetland EF
    PLoS One; 2015; 10(3):e0119326. PubMed ID: 25768005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing urogenital schistosomiasis and female genital schistosomiasis (FGS) among adolescents in Anaocha, Anambra State, Nigeria: implications for ongoing control efforts.
    Aribodor OB; Azugo NO; Jacob EC; Ngenegbo UC; Onwusulu ND; Obika I; Obikwelu EM; Nebe OJ
    BMC Public Health; 2024 Apr; 24(1):952. PubMed ID: 38566137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection status and risk factors associated with urinary schistosomiasis among school-going children in the Ndumo area of uMkhanyakude District in KwaZulu-Natal, South Africa two years post-treatment.
    Kabuyaya M; Chimbari MJ; Mukaratirwa S
    Int J Infect Dis; 2018 Jun; 71():100-106. PubMed ID: 29679769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
    Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
    Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with persistent transmission of
    Kajembe VR; Gasarasi DB; Tarimo DS; Lushina M; Sylvester B
    Trop Doct; 2022 Oct; 52(4):526-531. PubMed ID: 35918841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.